September 17, 2012
1 min read

Trials leader receives award

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Susan Goodin, PharmD, FCCP, BCOP

Susan Goodin, PharmD, FCCP, BCOP

Susan Goodin, PharmD, FCCP, BCOP, associate director of clinical trials and therapeutics at The Cancer Institute of New Jersey, received the 2012 Award of Excellence from the Hematology/Oncology Pharmacy Association.

The award recognizes Goodin’s significant and sustained contributions to hematology/oncology pharmacy, and for providing leadership in supporting or improving this area.

Goodin, a professor of medicine at UMDNJ-Robert Wood Johnson Medical School, leads the Cancer Institute of New Jersey’s clinical trials program. She also serves as director of the institute’s division of pharmaceutical sciences. In that role, she oversees the pharmacy team that provides medications for patients and educates those patients about usage, pain management and other related issues.

An active researcher, Goodin also studies investigational drugs via clinical trials and promotes the importance of such study as a way to help researchers unlock the mysteries of cancer.